What is a fibroadenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fibroadenoma: A Benign Breast Lesion

A fibroadenoma is the most common benign breast tumor, typically presenting as a smooth, rubbery, mobile mass that predominantly affects young women under the age of 40. 1

Clinical Characteristics

  • Presentation:

    • Smooth, rubbery, mobile mass on palpation
    • Usually painless
    • Typically unilateral
    • Most common in women under 40 years of age
    • May enlarge during pregnancy or hormonal changes 2
  • Physical Examination Findings:

    • Well-circumscribed
    • Mobile ("breast mouse" - moves freely within breast tissue)
    • Firm consistency
    • Usually 1-3 cm in diameter, though can be larger

Diagnostic Features

Imaging Characteristics

  • Ultrasound: Solid, round, well-circumscribed masses with homogeneous echogenicity, often with:

    • Oval or round shape
    • Abrupt well-defined margins
    • Orientation parallel to the chest wall
    • No posterior acoustic shadowing 3
  • Mammography: Well-circumscribed, round or oval masses, sometimes with lobulated features 1

Classification

Fibroadenomas can be classified as:

  1. Simple: Most common type
  2. Complex: Contains cysts >3 mm, epithelial calcifications, sclerosing adenosis, or papillary apocrine metaplasia
  3. Giant: >5 cm in diameter or >500 grams
  4. Juvenile/Myxoid: Occurs in adolescents 1, 2

Diagnosis and Management

Diagnostic Approach

The triple test is essential for accurate diagnosis:

  1. Clinical examination
  2. Imaging (ultrasound for younger women; ultrasound plus mammography for older women)
  3. Tissue sampling (fine needle aspiration or core biopsy) 4

Management Options

For typical fibroadenomas with benign features confirmed by the triple test, observation is appropriate and surgical excision is not routinely necessary. 3

Indications for surgical intervention include:

  • Diameter >2 cm
  • Rapid growth
  • Complex features on imaging
  • Patient symptoms or anxiety
  • Diagnostic uncertainty
  • Need to exclude phyllodes tumor 1

Important Distinctions

  • Phyllodes Tumor vs. Fibroadenoma:
    • Phyllodes tumors often appear similar to fibroadenomas on imaging
    • Clinical suspicion should be raised with:
      • Rapid growth
      • Large size (>2 cm)
      • History of growth 3
    • FNA and core biopsy may not reliably distinguish between them
    • Excisional biopsy may be needed for definitive diagnosis 3

Risk of Malignancy

The risk of malignancy in or adjacent to a fibroadenoma is very low (approximately 0.58% in core biopsied nodules) 5. The risk of cancer in a growing fibroadenoma is even rarer, with studies showing negligible incidence of malignant transformation 5.

Follow-up Recommendations

  • Fibroadenomas without epithelial abnormalities diagnosed by core biopsy generally require no specific follow-up due to the negligible risk of malignant transformation 5
  • For fibroadenomas managed conservatively, patients should be informed about the limitations of diagnostic tests and advised to seek prompt assessment if there are symptomatic or clinical changes 4

Common Pitfalls and Caveats

  1. Diagnostic Uncertainty: A clinical diagnosis alone is unreliable and does not exclude malignancy, even in younger women 4

  2. Distinguishing from Phyllodes Tumors: Large or rapidly growing fibroadenomas may be difficult to distinguish from phyllodes tumors, which require different management 3

  3. Pregnancy-Associated Growth: Fibroadenomas may rapidly enlarge during pregnancy due to hormonal changes, sometimes requiring intervention to prevent permanent breast tissue damage 2

  4. Complex Fibroadenomas: These require more careful evaluation as they may have slightly higher associated risk

References

Research

Fibroadenoma: a guide for junior clinicians.

British journal of hospital medicine (London, England : 2005), 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fibroadenoma of the breast.

The Medical journal of Australia, 2001

Research

The growing fibroadenoma.

Acta radiologica open, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.